Dr Ing hcF Porsche AG (P911) - Net Assets
Based on the latest financial reports, Dr Ing hcF Porsche AG (P911) has net assets worth €23.34 Billion EUR (≈ $27.29 Billion USD) as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€53.01 Billion ≈ $61.98 Billion USD) and total liabilities (€29.67 Billion ≈ $34.69 Billion USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check how resilient are Dr Ing hcF Porsche AG's assets to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €23.34 Billion |
| % of Total Assets | 44.03% |
| Annual Growth Rate | 5.75% |
| 5-Year Change | 14.0% |
| 10-Year Change | N/A |
| Growth Volatility | 17.92 |
Dr Ing hcF Porsche AG - Net Assets Trend (2019–2024)
This chart illustrates how Dr Ing hcF Porsche AG's net assets have evolved over time, based on quarterly financial data. Also explore how large is Dr Ing hcF Porsche AG's balance sheet for the complete picture of this company's asset base.
Annual Net Assets for Dr Ing hcF Porsche AG (2019–2024)
The table below shows the annual net assets of Dr Ing hcF Porsche AG from 2019 to 2024. For live valuation and market cap data, see market cap of Dr Ing hcF Porsche AG.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | €23.06 Billion ≈ $26.95 Billion |
+6.41% |
| 2023-12-31 | €21.67 Billion ≈ $25.33 Billion |
+27.26% |
| 2022-12-31 | €17.03 Billion ≈ $19.91 Billion |
-25.76% |
| 2021-12-31 | €22.93 Billion ≈ $26.81 Billion |
+13.40% |
| 2020-12-31 | €20.22 Billion ≈ $23.64 Billion |
+16.04% |
| 2019-12-31 | €17.43 Billion ≈ $20.38 Billion |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Dr Ing hcF Porsche AG's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 260.5% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €17.99 Billion | 78.08% |
| Other Components | €5.05 Billion | 21.92% |
| Total Equity | €23.04 Billion | 100.00% |
Dr Ing hcF Porsche AG Competitors by Market Cap
The table below lists competitors of Dr Ing hcF Porsche AG ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
CHINA RES.LAND UNS.ADR/10
F:CHZ0
|
$22.25 Billion |
|
Bayan Resources Tbk
JK:BYAN
|
$22.27 Billion |
|
Sieyuan Electric Co Ltd
SHE:002028
|
$22.29 Billion |
|
Zscaler Inc
NASDAQ:ZS
|
$22.30 Billion |
|
Regions Financial Corporation
NYSE:RF
|
$22.20 Billion |
|
Schindler Holding AG
SW:SCHN
|
$22.15 Billion |
|
WSP Global Inc
TO:WSP
|
$22.14 Billion |
|
Korea Shipbuilding & Offshore Engineering Co Ltd
KO:009540
|
$22.12 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Dr Ing hcF Porsche AG's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 21,667,000,000 to 23,043,000,000, a change of 1,376,000,000 (6.4%).
- Net income of 3,592,000,000 contributed positively to equity growth.
- Dividend payments of 2,101,000,000 reduced retained earnings.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €3.59 Billion | +15.59% |
| Dividends Paid | €2.10 Billion | -9.12% |
| Other Changes | €-115.00 Million | -0.5% |
| Total Change | €- | 6.35% |
Book Value vs Market Value Analysis
This analysis compares Dr Ing hcF Porsche AG's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.65x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has increased from 1.09x to 1.65x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2019-12-31 | €38.25 | €41.75 | x |
| 2020-12-31 | €44.39 | €41.75 | x |
| 2021-12-31 | €50.33 | €41.75 | x |
| 2022-12-31 | €37.36 | €41.75 | x |
| 2023-12-31 | €23.78 | €41.75 | x |
| 2024-12-31 | €25.29 | €41.75 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Dr Ing hcF Porsche AG utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 15.59%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 8.96%
- • Asset Turnover: 0.75x
- • Equity Multiplier: 2.32x
- Recent ROE (15.59%) is below the historical average (19.63%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2019 | 16.05% | 9.80% | 0.67x | 2.43x | €1.05 Billion |
| 2020 | 15.64% | 11.02% | 0.63x | 2.25x | €1.14 Billion |
| 2021 | 17.59% | 12.17% | 0.64x | 2.24x | €1.74 Billion |
| 2022 | 29.14% | 13.18% | 0.79x | 2.80x | €3.26 Billion |
| 2023 | 23.80% | 12.72% | 0.80x | 2.33x | €2.99 Billion |
| 2024 | 15.59% | 8.96% | 0.75x | 2.32x | €1.29 Billion |
Industry Comparison
This section compares Dr Ing hcF Porsche AG's net assets metrics with peer companies in the Auto Manufacturers industry.
Industry Context
- Industry: Auto Manufacturers
- Average net assets among peers: $40,100,524,525
- Average return on equity (ROE) among peers: 1.70%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Dr Ing hcF Porsche AG (P911) | €23.34 Billion | 16.05% | 1.27x | $22.23 Billion |
| Guangzhou Automobile Group Co. Ltd (02G) | $92.59 Billion | 7.92% | 0.67x | $1.01 Billion |
| Niu Technologies (0O9) | $993.37 Million | 16.98% | 0.86x | $205.33 Million |
| BAIC Motor Corp Ltd (2B5) | $58.03 Billion | 10.97% | 1.91x | $456.78 Million |
| XPENG INC. CL.A DL-00001 (8XP) | $31.27 Billion | -18.51% | 1.64x | $12.46 Billion |
| XPENG INC. SP.ADS/2 CL.A (8XPA) | $31.27 Billion | -18.51% | 1.64x | $12.52 Billion |
| ASTON MART.LA.UADR LS-001 (A5S0) | $611.40 Million | -31.34% | 3.65x | $390.66 Million |
| Bayerische Motoren Werke Aktiengesellschaft (BMW) | $21.74 Billion | 14.38% | 3.09x | $50.66 Billion |
| Bayerische Motoren Werke Aktiengesellschaft (BMW3) | $30.40 Billion | 16.73% | 3.34x | $4.80 Billion |
| China Yuchai International Limited (CYD) | $9.15 Billion | 7.98% | 1.05x | $1.31 Billion |
| Dongfeng Motor Group Company Limited (D4D) | $124.92 Billion | 10.39% | 0.81x | $3.00 Billion |
About Dr Ing hcF Porsche AG
Dr. Ing. h.c. F. Porsche AG engages in automotive and financial services business in Germany, rest of Europe, North America, China, and internationally. The company procures, develops, manufactures, and sells vehicles, as well as provides related services. It also offers leasing, dealer and customer financing, insurance brokerage, mobility, and other finance-related services. The company was form… Read more